Try our mobile app

Published: 2022-11-03 08:08:19 ET
<<<  go to SPNS company page
EX-99.1 2 ea167948ex99-1_sapiens.htm SAPIENS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

Exhibit 99.1

 

 

Sapiens Reports Third Quarter 2022 Financial Results

 

November 3, 2022 – Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2022.

 

Summary Results for Third Quarter 2022 (USD in millions, except per share data)

 

   GAAP       Non-GAAP     
   Q3 2022   Q3 2021   % Change   Q3 2022   Q3 2021   % Change 
Revenue  $119   $117.8    1.0%  $119   $118.4    0.5%
Gross Profit  $50.3   $48.3    4.1%  $53.5   $53.4    0.2%
Gross Margin   42.2%   41.0%   120bps   45.0%   45.1%   -10bps
Operating Income  $16.6   $16.2    2.1%  $20.9   $21.0    -0.6%
Operating Margin   13.9%   13.8%   10bps   17.6%   17.7%   -10bps
Net Income (*)  $13.4   $13.3    0.9%  $16.9   $17.0    -0.6%
Diluted EPS  $0.24   $0.24    0.0%  $0.30   $0.31    -3.2%

 

(*)Attributable to Sapiens’ shareholders

 

Roni Al-Dor, President and CEO of Sapiens, stated, “Our revenue reached $119 million, and on a constant currency basis, we grew by 8%. Operating profit this quarter reached $20.9 million, representing an operating margin of 17.6%. This quarter, we delivered solid results excluding the currency headwind. Sapiens’ business model proves itself with continued growth and improved profitability, with a diversified product platform containing core systems in P&C, Life & Annuity and various business applications delivered on the cloud. We have a global presence with both onshore and offshore operations.”

 

Mr. Al-Dor continued, “Today, we are revising our 2022 revenue guidance to a new range of $472 to $478 million from $480 to $485 million, primarily due to delays in signing new deals caused by macroeconomics and the impact of foreign exchange. The new revenue guidance reflects annual growth of 2.5%, and on a constant currency basis a growth of 8.4%. Despite the continuous weakening of the European currencies versus the dollar, we are reaffirming our profit margin guidance range of 17.5%-17.7%.”

 

 

 

 

Management will host a conference call and webcast today, November 3rd, 2022, at 9:30 a.m. Eastern Time (3:30 pm in Israel) to review and discuss Sapiens’ results.

 

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

 

North America (toll-free): + 1-888-642-5032; International: +972-3-918-0609; UK: 0-800-917-5108

 

The live webcast of the call can be viewed on Sapiens’ website at: https://veidan.activetrail.biz/sapiensq3-2022. A replay of the call will be available one business day following the completion of the event, at the same link for 90 days.

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens’ financial condition and results of operations. The Company’s management uses these non-GAAP measures to compare the Company’s performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company’s financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

 

2

 

 

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

 

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company’s business.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

The Company defines Adjusted EBITDA as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

 

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

 

3

 

 

About Sapiens

 

Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative and agile. Backed by more than 35 years of industry expertise, Sapiens offers a complete insurance platform, with pre-integrated, low-code solutions and a cloud-first approach that accelerates customers’ digital transformation. Serving over 600 customers in 30 countries, Sapiens offers insurers across property and casualty, workers compensation and life markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management.  For more information visit www.sapiens.com or follow us on LinkedIn.

 

Investor Contact

 

Dina Vince
Head of Investor Relations
D
ina.Vince@sapiens.com

Media Contact

 

Tally Kaplan Porat
Director of Corporate Marketing
tally.kaplanporat@sapiens.com

 

4

 

 

Forward Looking Statements

 

Certain matters discussed in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, and are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers’ systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Risk Factors” in our most recent Annual Report on Form 20-F, which we filled with the SEC on March 31, 2022, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

 

5

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENT OF INCOME

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2022   2021   2022   2021 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
Revenue   118,996    117,812    355,273    341,810 
Cost of revenue   68,721    69,512    205,415    202,630 
                     
Gross profit   50,275    48,300    149,858    139,180 
                     
Operating expenses:                    
Research and development, net   14,804    13,767    43,405    40,122 
Selling, marketing, general and administrative   18,919    18,316    56,443    57,302 
Total operating expenses   33,723    32,083    99,848    97,424 
                     
Operating income   16,552    16,217    50,010    41,756 
                     
Financial and other expenses, net   (82)   (72)   2,038    512 
Taxes on income   2,893    2,923    8,342    7,560 
                     
Net income   13,741    13,366    39,630    33,684 
                     
Attributable to non-controlling interest   348    97    401    177 
                     
Net income attributable to Sapiens’ shareholders   13,393    13,269    39,229    33,507 
                     
Basic earnings per share   0.25    0.24    0.72    0.61 
                     
Diluted earnings per share   0.24    0.24    0.71    0.60 
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   55,124    54,787    55,109    54,732 
                     
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   55,581    55,611    55,595    55,564 

 

6

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

 

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2022   2021   2022   2021 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
GAAP revenue   118,996    117,812    355,273    341,810 
Valuation adjustment on acquired deferred revenue   23    630    69    1,889 
Non-GAAP revenue   119,019    118,442    355,342    343,699 
                     
GAAP gross profit   50,275    48,300    149,858    139,180 
Revenue adjustment   23    630    69    1,889 
Amortization of capitalized software   1,442    1,920    4,323    5,595 
Amortization of other intangible assets   1,806    2,563    5,446    7,697 
Non-GAAP gross profit   53,546    53,413    159,696    154,361 
                     
GAAP operating income   16,552    16,217    50,010    41,756 
Gross profit adjustments   3,271    5,113    9,838    15,181 
Capitalization of software development   (1,492)   (2,064)   (4,859)   (5,655)
Amortization of other intangible assets   1,269    1,342    3,668    4,066 
Stock-based compensation   1,141    657    3,201    3,527 
Acquisition-related costs *)   161    (246)   561    938 
Non-GAAP operating income   20,902    21,019    62,419    59,813 
                     
GAAP net income attributable to Sapiens’ shareholders   13,393    13,269    39,229    33,507 
Operating income adjustments   4,350    4,802    12,408    18,057 
Taxes on income   (872)   (1,095)   (2,489)   (3,707)
Non-GAAP net income attributable to Sapiens’ shareholders   16,871    16,976    49,148    47,857 

 

(*)Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as tax, accounting and legal rendered until the acquisition date.

 

7

 

 

Adjusted EBITDA Calculation
U.S. dollars in thousands

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2022   2021   2022   2021 
                 
GAAP operating profit   16,552    16,217    50,010    41,756 
                     
Non-GAAP adjustments:                    
Valuation adjustment on acquired deferred revenue   23    630    69    1,889 
Amortization of capitalized software   1,442    1,920    4,323    5,595 
Amortization of other intangible assets   3,075    3,905    9,114    11,763 
Capitalization of software development   (1,492)   (2,064)   (4,859)   (5,655)
Stock-based compensation   1,141    657    3,201    3,527 
Compensation related to acquisition and acquisition-related costs   161    (246)   561    938 
                     
Non-GAAP operating profit   20,902    21,019    62,419    59,813 
                     
Depreciation   1,134    1,125    3,208    3,371 
                     
Adjusted EBITDA   22,036    22,144    65,627    63,184 

 

Summary of NON-GAAP Financial Information
U.S. dollars in thousands (except per share amounts)

 

   Q3 2022   Q2 2022   Q1 2022   Q4 2021   Q3 2021 
                     
Revenues   119,019    118,605    117,718    119,854    118,442 
Gross profit   53,546    53,207    52,943    53,933    53,413 
Operating income   20,902    20,747    20,770    21,590    21,019 
Adjusted EBITDA   22,036    21,681    21,910    23,579    22,144 
Net income to Sapiens’ shareholders   16,871    14,979    17,298    17,681    16,976 
                          
Diluted earnings per share   0.30    0.27    0.31    0.32    0.31 

 

8

 

 

Non-GAAP Revenues by Geographic Breakdown
U.S. dollars in thousands

 

   Q3 2022   Q2 2022   Q1 2022   Q4 2021   Q3 2021 
                     
North America   49,555    48,154    49,009    48,872    48,952 
Europe   56,887    59,868    59,267    62,416    59,707 
Rest of the World   12,577    10,583    9,442    8,566    9,783 
                          
Total   119,019    118,605    117,718    119,854    118,442 

 

Adjusted Free Cash-Flow
U.S. dollars in thousands

 

   Q3 2022   Q2 2022   Q1 2022   Q4 2021   Q3 2021 
                     
Cash-flow from operating activities   4,405    6,615    18,330    27,386    14,556 
Increase in capitalized software development costs   (1,492)   (1,621)   (1,746)   (2,256)   (2,064)
Capital expenditures   (1,047)   (803)   (453)   (801)   (1,082)
Free cash-flow   1,866    4,191    16,131    24,329    11,410 
                          
Cash payments attributed to acquisition-related costs(*) (**)   -    -    -    407    477 
                          
Adjusted free cash-flow   1,866    4,191    16,131    24,736    11,887 

 

(*)Included in cash-flow from operating activities

 

(**)Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

 

9

 

 

Reconciliation of Revenue Growth as Reported on GAAP Basis to Revenue Growth on a Constant Currency Basis

 

Three months ended September 30, 2022

 

Revenue growth %  As reported   Currency Impact   Constant Currency Basis 
North America   1.2%   -    1.2%
Europe   (4.7)%   (14.8)%   10.0%
Rest of the world   28.6%   (0.9)%   29.5%
Total   0.5%   (7.5)%   8.0%

 

Nine months ended September 30, 2022

 

Revenue growth %  As reported   Currency Impact   Constant Currency Basis 
North America   4.4%   -    4.4%
Europe   (0.6)%   (10.4)%   9.8%
Rest of the world   24.6%   (0.6)%   25.2%
Total   3.4%   (5.4)%   8.8%

 

* Constant currency revenue results are calculated by translating current period revenues in local currency into U.S dollars at the weighted average exchange rates of the comparable prior period.
 

* Due to the significant impact of the currencies fluctuations this year on our reported revenues, we are providing the above information by region on a constant currency basis for this quarter and the remaining of 2022. We are not committing at this time to continue providing such information in the future.

 

10

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEET

U.S. dollars in thousands

 

   September 30,   December 31, 
   2022   2021 
   (unaudited)   (unaudited) 
         
ASSETS        
         
CURRENT ASSETS        
Cash and cash equivalents   146,916    190,243 
Short-term bank deposit   20,000    20,000 
Trade receivables, net and unbilled receivables   89,992    76,261 
Other receivables and prepaid expenses   12,231    13,841 
Total current assets   269,139    300,345 
           
LONG-TERM ASSETS          
Property and equipment, net   12,421    14,458 
Severance pay fund   4,267    5,954 
Goodwill and intangible assets, net   315,454    343,283 
Operating lease right-of-use assets   34,267    43,665 
Other long-term assets   6,607    7,288 
Total long-term assets   373,016    414,648 
           
TOTAL ASSETS   642,155    714,993 
           
LIABILITIES AND EQUITY          
           
CURRENT LIABILITIES          
Trade payables   11,772    5,008 
Current maturities of Series B Debentures   19,796    19,796 
Accrued expenses and other liabilities   70,412    76,450 
Current maturities of operating lease liabilities   9,161    10,827 
Deferred revenue   32,110    39,614 
Total current liabilities   143,251    151,695 
           
LONG-TERM LIABILITIES          
Series B Debentures, net of current maturities   59,251    78,986 
Deferred tax liabilities   14,000    15,360 
Other long-term liabilities   11,903    12,144 
Long-term operating lease liabilities   29,338    38,751 
Redeemable non-controlling interest   88    101 
Accrued severance pay   7,166    9,236 
Total long-term liabilities   121,746    154,578 
           
EQUITY   377,158    408,720 
           
TOTAL LIABILITIES AND EQUITY   642,155    714,993 

 

11

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONSOLIDATED STATEMENT OF CASH FLOW
U.S. dollars in thousands

 

   For the Nine months ended
September 30,
 
   2022   2021 
   (unaudited)   (unaudited) 
Cash flows from operating activities:        
Net income   39,630    33,684 
Reconciliation of net income to net cash provided by operating activities:          
Depreciation and amortization   16,645    20,729 
Accretion of discount on Series B Debentures   61    76 
Capital (gain) loss from sale of property and equipment   27    (60)
Stock-based compensation related to options issued to employees   3,201    3,527 
           
Net changes in operating assets and liabilities, net of amount acquired:          
Trade receivables, net and unbilled receivables   (21,386)   (14,673)
Deferred tax liabilities, net   (978)   (3,777)
Other operating assets   5,475    12,122 
Trade payables   7,527    3,520 
Other operating liabilities   (15,122)   (1,292)
Deferred revenues   (5,686)   (810)
Accrued severance pay, net   (44)   110 
Net cash provided by operating activities   29,350    53,156 
           
Cash flows from investing activities:          
Purchase of property and equipment   (2,334)   (2,985)
Proceeds from (Investment in) deposits   (133)   (9,989)
Proceeds from sale of property and equipment   31    1,112 
Proceeds from (payments for) business acquisitions, net of cash acquired   (3,467)   831 
Capitalized software development costs   (4,859)   (5,655)
Net cash provided by (used in) investing activities   (10,762)   (16,686)
           
Cash flows from financing activities:          
Proceeds from employee stock options exercised   -    1,028 
Distribution of dividend   (38,579)   (20,255)
Repayment of Series B Debenture   (19,796)   (19,796)
Payment of contingent considerations   -    (926)
Acquisition of non-controlling interests   -    (990)
Dividend to non-controlling interest   -    (31)
Net cash used in financing activities   (58,375)   (40,970)
           
Effect of exchange rate changes on cash and cash equivalents   (3,540)   (3,347)
           
Decrease in cash and cash equivalents   (43,327)   (7,847)
Cash and cash equivalents at the beginning of period   190,243    152,561 
           
Cash and cash equivalents at the end of period   146,916    144,714 

 

12

 

 

Debentures Covenants

 

As of September 30, 2022, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

 

Covenant 1

 

Target shareholders’ equity (excluding non-controlling interest): above $120 million.

 

Actual shareholders’ equity (excluding non-controlling interest) equal to $374.8 million.

 

Covenant 2

 

Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company’s Series B Debentures) below 65%.

 

Actual ratio of net financial indebtedness to net capitalization equal to (29.38)%.

 

Covenant 3

 

Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the three last quarters) is below 5.5.

 

Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the three last quarters) is equal to (0.96).

 

 

13